DrugPatentWatch Database Preview

Details for Patent: 8,048,917

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,048,917 protect, and when does it expire?

Patent 8,048,917 protects HORIZANT and is included in one NDA.

This patent has seventy-three patent family members in twenty countries.

Summary for Patent: 8,048,917

Title:	Prodrugs of GABA analogs, compositions and uses thereof
Abstract:	The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.
Inventor(s):	Gallop; Mark A. (Los Altos, CA), Cundy; Kenneth C. (Redwood City, CA), Zhou; Cindy X. (Palo Alto, CA), Yao; Fenmei (Mountain View, CA), Xiang; Jia-Ning (Palo Alto, CA)
Assignee:	XenoPort, Inc. (Santa Clara, CA)
Application Number:	11/110,909
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form; Use;

Drugs Protected by US Patent 8,048,917

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Arbor Pharms Llc	HORIZANT	gabapentin enacarbil	TABLET, EXTENDED RELEASE;ORAL	022399-002	Dec 13, 2011		RX	Yes	No			Y	Y		MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS
Arbor Pharms Llc	HORIZANT	gabapentin enacarbil	TABLET, EXTENDED RELEASE;ORAL	022399-001	Apr 6, 2011		RX	Yes	Yes			Y	Y		MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS

International Family Members for US Patent 8,048,917

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	380029
Austria	540678
Australia	2002310409
Australia	2002345664
Australia	2003247522
Australia	2003297676
Australia	2007203364